Skip to content

BBNX BBNX Gross Profit

Gross Profit at other companies

Insulet logo
InsuletPODD
$529M+29.3%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$136.79M+15.5%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
AdaptHealth logo
AdaptHealthAHCO
$111.5M-7.4%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Calculated from BBNX’s reported figures.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's gross profit?
BBNX (BBNX) reported gross profit of $16.44M in Q1 2026.
How has BBNX's gross profit changed year-over-year?
BBNX's gross profit increased by 83.2% year-over-year, from $8.97M to $16.44M.
What is the long-term trend for BBNX's gross profit?
Over 2 years (2023 to 2025), BBNX's gross profit has grown at a 196.7% compound annual growth rate (CAGR), from $6.31M to $55.54M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.